Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.
about
Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus.Stillbirth: the impact of antiphospholipid syndrome?Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.Obstetric antiphospholipid syndromeFetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study
P2860
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@ast
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@en
type
label
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@ast
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@en
prefLabel
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@ast
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@en
P2093
P2860
P1476
Lupus anticoagulant is the mai ...... ion of PROMISSE study results.
@en
P2093
Carl A Laskin
Cecile M Yelnik
D Ware Branch
Jane E Salmon
Jill P Buyon
Joan T Merrill
Lisa R Sammaritano
Marta M Guerra
Mimi Y Kim
T Flint Porter
P2860
P304
P356
10.1136/LUPUS-2015-000131
P577
2016-01-12T00:00:00Z